FORMELA JEAN FRANCOIS sold $6K of KRRO (indirect holdings)
FORMELA JEAN FRANCOIS sold 419 indirectly-held shares of Korro Bio, Inc. (KRRO) at $13.95 on 2026-05-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale may influence short-term sentiment, but the 10b5-1 designation generally lowers the likelihood of a strong directional fundamental signal.
Market read
Traders may monitor for follow-on insider activity, but this specific disclosure alone is unlikely to drive a major repricing.
What to watch
The filing does not reveal whether other insiders increased/decreased holdings around the same time, which could matter more than a single director sale.
Background
This is an SEC Form 4 insider transaction disclosure for Korro Bio, Inc. (KRRO).
Ticker impact
Korro Bio director Formela Jean Francois sold 419 shares in an open-market transaction disclosed via SEC Form 4 on May 28.
Likely limited near-term impact; any reaction should be muted given the 10b5-1 pre-arranged nature.
The filing provides a specific sale price/value but does not indicate distress, new guidance, or operational change; 10b5-1 plans typically reduce interpretive signal.
Market effects
Minimal; this is company-specific insider activity without sector-wide read-across.
None.
None.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.
Key entities
- issuerKorro Bio, Inc.
Subject of the insider transaction disclosure (KRRO).
- directorFormela Jean Francois
Director who sold 419 shares under a pre-arranged 10b5-1 plan.